INDUSTRY NEWS

INDUSTRY NEWS
Arthur Cummings
Published: Thursday, December 10, 2015

 

FEMTOSECOND LASER PLATFORM

Heidelberg Engineering has signed a new agreement with Valeant to continue to supply the swept-source optical coherence tomography (OCT) module for the VICTUS® Femtosecond Laser Platform, commercialised under the Bausch+Lomb/Technolas brand.

The VICTUS® Femtosecond Laser Platform is used for cataract and corneal applications.

“Heidelberg Engineering delivers its advanced swept-source OCT module, which allows for real-time visualisation during every step of the surgery, from docking through planning and treatment,” said a company spokeswoman.

“The swept-source OCT module features high-quality images at video frame rate. It provides excellent imaging contrast and sensitivity for the autorecognition of key landmarks (pupil, lens, anterior and posterior capsule), boosting surgeons’ confidence and control during surgical procedures,” she said.

www.heidelbergengineering.com | www.valeant.com

 

MOBILE SOLUTION
The US Food and Drug Administration (FDA) has granted approval for use of the Ziemer FEMTO LDV Z8 in the USA.
“The FEMTO LDV Z8 was launched in Europe and selected Asian countries in mid-2014, with adoption steadily increasing since that time. It is the first truly mobile femtosecond laser solution for refractive, cornea and cataract procedures to be performed on an all-in-one system,” said a spokeswoman for Ziemer Ophthalmic Systems AG.
Zeimer say the FEMTO LDV Z8 uses unique technology that provides precision in the cornea and power in the lens, with use of adjustable pulse energy combined with a high repetition rate to provide a precise capsulotomy and lens fragmentation.

www.femtoldv.com

 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...